title: Periodic benefit-risk evaluation reports have substantial promise to guide patient care and should be made publicly available.
authors.affiliation: Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvarde Medical School, Boston, MA, USA.|University of Toronto Clinician-Scientist Program, Toronto, ON, Canada.
authors.forename: Michael
authors.identifier: 0000-0002-2082-2445
authors.initials: M
authors.lastname: Fralick
authors.affiliation: Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvarde Medical School, Boston, MA, USA.
authors.forename: Aaron S
authors.initials: AS
authors.lastname: Kesselheim
mesh_terms: D030881:Disclosure; D017277:Drug Approval; D064420:Drug-Related Side Effects and Adverse Reactions / Q000453:epidemiology*; D006801:Humans; D005791:Patient Care / Q000592:standards*; D014481:United States; D014486:United States Food and Drug Administration